How Does The Additional Benefit Extent of Orphan Drugs Impact Price Negotiations In The German Outpatient Sector?
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1760
https://www.valueinhealthjournal.com/article/S1098-3015(15)03836-X/fulltext
Title :
How Does The Additional Benefit Extent of Orphan Drugs Impact Price Negotiations In The German Outpatient Sector?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03836-X&doi=10.1016/j.jval.2015.09.1760
First page :
A550
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1193